Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents-Reference-Cited by-同舟云学术

Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents

Published:2021-11-15 Issue: Volume: Page:1-8
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Shah Harsh¹^ORCID,Jang Hyejeong²,Singh Paramveer²,Kosti Jorgena²,Kin Andrew²,Alavi Asif²,Ratanatharathorn Voravit²,Ayash Lois²,Uberti Joseph²,Ramchandren Radhakrishnan³,Kim Seongho²,Deol Abhinav²

Affiliation:

1. Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA

2. Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA

3. Division of Hematology/Oncology University of Tennessee, Knoxville, TN, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2002322

Reference30 articles.

1. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

2. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

3. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

4. Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

5. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies;Leukemia & Lymphoma;2024-01-02

2. Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessation;MedComm;2023-11-22

3. Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary;Annals of Hematology;2023-07-10

4. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26

5. Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study;Cancers;2022-11-27